Evidence map›Paper›PMID 25463433›Full record

ArticleClinical immunology (Orlando, Fla.)2015

The effect of the autoimmunity-associated gene, PTPN22, on a BXSB-derived model of lupus.

Christian J Maine, Kristi Marquardt, John C Scatizzi, K Michael Pollard, Dwight H Kono, Linda A Sherman

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Protein phosphatases in systemic autoimmunity.Immunometabolism (Cobham, Surrey) · 2025
    Review
  2. Article
  3. Review
  4. Overexpression of theJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  5. Influence ofFrontiers in immunology · 2021
    Review
  6. Functional Characterization of CD11cJournal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  7. Generation of functional murine CD11cEuropean journal of immunology · 2019
    Article
  8. Article
  9. PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Christian J MaineDepartment of Immunity and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
Kristi MarquardtDepartment of Immunity and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
John C ScatizziDepartment of Immunity and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
K Michael PollardDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
Dwight H KonoDepartment of Immunity and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
Linda A ShermanDepartment of Immunity and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: lsherman@scripps.edu.
Scripps Research Institute · US

Funding

PATHOGENESIS AND IMMUNOLOGY OF DISEASET32AI007244 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1985 to 2022
$8.8M
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NODU01AI070351 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SHERMAN, LINDA A · 2006 to 2011
$5.4M
THYMIC AND PERIPHERAL CD8+ T CELL TOLERANCER01DK050824 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI SHERMAN, LINDA A · 1995 to 2014
$5.0M
Influence of Innate Immunity on Xenobiotic-Induced Systemic AutoimmunityR01ES021464 · NIEHS · SCRIPPS RESEARCH INSTITUTE, THE · PI POLLARD, KENNETH MICHAEL · 2013 to 2017
$3.4M
Xenobiotic-Induced Type 1 Interferon-Independent AutoimmunityR01ES022625 · NIEHS · SCRIPPS RESEARCH INSTITUTE, THE · PI POLLARD, KENNETH MICHAEL · 2014 to 2018
$2.1M
Genetics of Autoimmune Hemolytic AnemiaR01HL114408 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI KONO, DWIGHT H · 2013 to 2016
$1.9M
NHLBI NIH HHS HL114408NHLBI NIH HHS R01 HL114408NIAID NIH HHS T32 AI007244NIAID NIH HHS U01 AI070351NIDDK NIH HHS DK050824-20NIDDK NIH HHS R01 DK050824NIEHS NIH HHS ES021464NIEHS NIH HHS ES022625NIEHS NIH HHS R01 ES021464NIEHS NIH HHS R01 ES022625
6 · The paper itself

Abstract

A single nucleotide polymorphism in PTPN22 is linked to increased disease susceptibility in a range of autoimmune diseases including systemic lupus erythematosus (SLE). PTPN22 encodes the Lyp phosphatase that dampens TCR signaling and is necessary for signaling downstream of toll-like receptors in myeloid cells. To understand these dual functions in disease, we examined the impact of deficiency in PTPN22 on a spontaneous murine model of SLE. Male PTPN22 KO mice carrying BXSB chromosome 1 and the Yaa disease accelerating factor developed disease at a similar rate and severity as PTPN22 WT. In contrast, although female mice showed no differences in survival in the absence of PTPN22, autoantibody production was significantly increased and splenic populations associated with pathogenesis in this model were expanded in the PTPN22 KO group. These findings support the notion that when coupled with other predisposing autoimmunity genes, PTPN22 deficiency contributes to a predisposition to lupus pathogenesis.

Indexed as

Disease Models, AnimalAnimalsFemaleFlow CytometryLupus Erythematosus, SystemicMaleMiceMice, KnockoutProtein Tyrosine Phosphatase, Non-Receptor Type 22Protein Tyrosine Phosphatase, Non-Receptor Type 22PTPN22 protein, humanAutoantibodiesBXSBPTPN22Systemic lupus erythematosusT follicular helper cellsTolerance

Identifiers

PMID25463433
PMCPMC4291082
OpenAlexW2048531198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.